Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × DILI × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2479 Neoplasms 2243 Lung Neoplasms 1136 Colorectal Neoplasms 1114 Prostatic Neoplasms 1045 Carcinoma, Non-Small-Cell Lung 911 Carcinoma, Hepatocellular 663 Stomach Neoplasms 609 Pancreatic Neoplasms 590 Ovarian Neoplasms 494 Colonic Neoplasms 441 Uterine Cervical Neoplasms 419 Head and Neck Neoplasms 410 Rectal Neoplasms 400 Multiple Myeloma 399 Melanoma 398 Esophageal Neoplasms 363 Neoplasm Metastasis 362 Brain Neoplasms 349 Urinary Bladder Neoplasms 332 Lymphoma 329 Precursor Cell Lymphoblastic Leukemia-Lymphoma 324 Leukemia, Myeloid, Acute 318 Carcinoma, Renal Cell 289 Leukemia 280 Hematologic Neoplasms 268 Liver Neoplasms 262 Endometrial Neoplasms 262 Recurrence 247 Glioma 228

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡